Speaker Profile
Biography
Nathan Price focuses on advancing AI-enabled scientific wellness and bringing precision medicine into proactive practice. His work integrates multi-omics, digital biomarkers, and computational modeling to detect early signals of aging, resilience, and diseaseand to translate them into personalized, actionable guidance. He is building next-generation AI platforms designed to operationalize precision health at scale. Price has authored 220 scientific publications and led landmark longitudinal wellness studies. He co-authored The Age of Scientific Wellness. He has written for major outlets including The Wall Street Journal, LA Times, and Scientific American, and been a guest on leading podcasts such as Armchair Expert, The Doctors Farmacy, and Keeping It Real with Jillian Michaels. His recognitions include being an Emerging Leader for the National Academy of Medicine, service on the National Academies Board on Life Sciences, Fellowship in A IMBE, and the 2023 Alex and er Mildred Seelig Award from the American Nutrition Association.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Michael Goldman, SFSU
PMWC Award Ceremony
• David Sinclair, Harvard
• Steve Horvath, Altos Labs
• Nir Barzilai, Albert Einstein College of Medicine
AI-Driven Biomarkers to Quantify Aging
• Chair: Alex Zhavoronkov, Insilico Medicine
• Mahdi Moqri, Harvard
• Steve Horvath, Altos Labs
• Hussain Ahamed, Ultrahuman
Epigenetic Aging Signatures in Large Human Cohorts
• Varun Dwaraka, TruDiagnostic
AI Systems for Personalized Longevity: How Biomarkers Translate into Actionable Interventions
• Chair: Nathan Price, Buck Institute
• Sherry Zhang, Buck Institute
• Ranjan Sinha, Digbi Health
• Zeenia Framroze, Alethios, Inc.
Telomere Extension Clinical Trials Under LARTA/FDA
• John Ramunas, Rejuvenation Technologies
Clinical Trial Design & Functional Endpoints for Healthspan
• Nir Barzilai, Albert Einstein College of Mediciney
The data We Need For AI To Accelerate Longevity Drugs
• Martin Jensen, Gordian Biotechnology
From Genome to an AI-Drive Longevity Platform
• Wei-Wu He, Human Longevity
Wellness Wearables: The Journey to Clinical
• Hussain Ahamed, Ultrahuman
Longevity Medicine: Ambition vs Evidence in the Era of Precision Health
• Aubrey de Grey, LEV Foundation
Precision Aging & Longevity Focused on Limited Lifespan Evidence, Vanishing Blue Zones, and Payer ROI
• S. Jay Olshansky, University of Illinois
Evolutionary perspectives on human lifespan and healthspan
• Michael Gurven, UC Santa Barbara




